Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.64 is 66% below its 5-year average of 7.85, near the low end of its 5-year range (2.64–32.99).
As of the fiscal period ended Tuesday, June 30, 2026. 47.80% below its 12-month average of 5.06.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.64.
QUICK RATIO (ACID-TEST)
2.64
QUICK RATIO (ACID-TEST) AVG TTM
5.06
QUICK RATIO (ACID-TEST) AVG 3Y
6.43
QUICK RATIO (ACID-TEST) AVG 5Y
7.85
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-47.80%
CURRENT VS 3Y AVG
-58.95%
CURRENT VS 5Y AVG
-66.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-21.20%
vs the sector median at left
Strata Critical Medical, Inc.
Market Cap
$411.00M
Quick Ratio (Acid-Test)
2.64
TTM Avg
5.06
3Y Avg
6.43
5Y Avg
7.85
Market Cap
$411.21M
Quick Ratio (Acid-Test)
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$406.58M
Quick Ratio (Acid-Test)
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$415.98M
Quick Ratio (Acid-Test)
9.44
TTM Avg
11.90
3Y Avg
14.34
5Y Avg
23.42
Market Cap
$405.74M
Quick Ratio (Acid-Test)
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$416.27M
Quick Ratio (Acid-Test)
6.40
TTM Avg
3.40
3Y Avg
4.68
5Y Avg
4.62
Market Cap
$404.24M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.95
3Y Avg
1.91
5Y Avg
2.07
Market Cap
$418.95M
Quick Ratio (Acid-Test)
3.19
TTM Avg
3.65
3Y Avg
4.66
5Y Avg
6.11
Market Cap
$402.17M
Quick Ratio (Acid-Test)
10.64
TTM Avg
18.70
3Y Avg
14.71
5Y Avg
15.03
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | $411.00M | 2.64 | 5.06 | 6.43 | 7.85 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 16.52 | 13.61 | 8.86 | 8.86 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 9.89 | 6.34 | 6.34 | 6.34 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 9.44 | 11.90 | 14.34 | 23.42 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 8.13 | 16.34 | 21.67 | 17.16 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 6.40 | 3.40 | 4.68 | 4.62 |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | 1.98 | 1.95 | 1.91 | 2.07 |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 3.19 | 3.65 | 4.66 | 6.11 |
| Neurogene Inc. (NGNE)vs › | $402.17M | 10.64 | 18.70 | 14.71 | 15.03 |
| Prothena Corporation plc (PRTA)vs › | $419.87M | 25.05 | 8.87 | 10.83 | 12.06 |
Quick Ratio
2.64
Excludes inventory
Current Ratio
2.64
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.64 |
| 2026-03-31 | 5.93 |
| 2025-12-31 | 6.38 |
| 2025-09-30 | 4.39 |
| 2025-06-30 | 5.95 |
| 2025-03-31 | 6.96 |
| 2024-12-31 | 7.07 |
| 2024-09-30 | 6.32 |
| 2024-06-30 | 6.04 |
| 2024-03-31 | 8.35 |
| 2023-12-31 | 5.81 |
| 2023-09-30 | 6.83 |
| 2023-06-30 | 7.14 |
| 2023-03-31 | 9.01 |
| 2022-12-31 | 8.20 |
| 2022-09-30 | 11.14 |
| 2022-06-30 | 15.03 |
| 2022-03-31 | 18.07 |
| 2021-12-31 | 32.99 |
| 2021-09-30 | 23.03 |
| 2021-06-30 | 32.46 |
| 2021-03-31 | 0.40 |
| 2020-12-31 | 2.29 |
| 2020-09-30 | 2.19 |
| 2020-06-30 | 2.34 |
| 2020-03-31 | 2.59 |
| 2019-12-31 | 3.85 |
| 2019-09-30 | 5.15 |
